Interest in the assessment of QoL in urological patients is growing. This is especially true for patients suffering from prostate cancer. Questionnaires have been developed to measure cancer-speci®c QoL, while disease speci®c modules are constructed to supplement these general questionnaires. However, none of these questionnaires include psychosocial measures. It has been repeatedly suggested that the assessment of QoL might be in¯uenced by psychosocial factors such as coping style, mood, ability to express emotions, stressful life events and social support.
We studied the in¯uence of psychosocial factors on the assessed QoL in patients with BPH and PC.
Method
This study involves patients referred because they were suspected of having PC (eg elevated PSA or suspicious digital rectal examination). All patients had a full urological work-up. Patients ®lled out an extended questionnaire just prior to the ®nal diagnosis (t1) and 3 months after the diagnosis (t2). The questionnaire applied was constructed by using standard instruments in order to measure several QoL (EORTC-QLQ-C30) and psychosocial aspects such as coping style (UCL, COPE), nonexpression of emotions (MAC), stressful life events (LES, IES) and social support (SSQ).
Results
Eighty two patients were included (BPH, n 50, PC, n 32). Except for a signi®cant difference in the PSA level (mean 11.0 ng/ml in BPH and 27.4 ng/ml in PC) no differences were found for any other urological parameter. The same is true for the measured QoL and the psychosocial pro®le in both groups at baseline. After 3 months, QoL (several domains) in PC was signi®cantly worse when compared with BPH. Again no differences were found for the psychosocial pro®le. Co-variance analyses showed that psychosocial factors did not explain the differences in QoL at t1 and t2 in PC patients.
Conclusion
In the present study, the changes in QoL were not in¯uenced by psychosocial factors. This means that the QoL assessment used truly measures the impact of the disease and its treatment.
